Choosing PD-1 Inhibitors in Oncology Setting, Left or Right?-Lessons From Value Assessment With ASCO-VF and ESMO-MCBS

• Asıl Yazarlar: Qian Jiang (Yazar), Mei Feng (Yazar), Youping Li (Yazar), Jinyi Lang (Yazar), Hua Wei (Yazar), Ting Yu (Yazar)
• Materyal Türü: Kitap
• Baskı/Yayın Bilgisi: Frontiers Media S.A., 2020-12-01T00:00:00Z.
• Konular: article
• Online Erişim: Connect to this object online.

Background: Influx of innovative therapies and dramatic rise in prices have been prompting value-driven decision-making. Both the American Society of Clinical Oncology (ASCO) and the European Society for Medical Oncology (ESMO) have independently proposed value assessment frameworks.Objectives: To c...